TOlerability of Transcranial Direct Current Stimulation in Pediatric Stroke Survivors (NCT05812794) | Clinical Trial Compass
CompletedNot Applicable
TOlerability of Transcranial Direct Current Stimulation in Pediatric Stroke Survivors
United States5 participantsStarted 2023-06-30
Plain-language summary
The purpose of this study is to evaluate the tolerability of tDCS in childhood stroke survivors and to assess for improvement in arm function in patients receiving tDCS and occupational therapy
Who can participate
Age range5 Years – 19 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Childhood stroke survivor - either arterial ischemic stroke or intracerebral hemorrhage.
* Stroke must be childhood onset, defined as occurring day 29 of life to 18 years of age (per the American Heart Association's definition of childhood stroke)
* 3 months or greater from stroke onset
* Arm impairment, defined as pediatric stroke outcome measure of 1 or greater of affected arm.
* Affected arm Fugl-Meyer score of 60 or lower.
* Able to participate in occupational therapy sessions.
Exclusion Criteria:
* Uncontrolled epilepsy, defined as seizure within the past 6 months.
* Craniectomy without replacement of bone flap. Patients who underwent craniectomy will need the bone flap reattached prior to participation.
* Presence of cranial metal implants or implant device that could be affected by tDCS: cochlear implant, implanted brain stimulator, or programmable ventriculoperitoneal shunt.
What they're measuring
1
Number of Participants Who Complete the Study
Timeframe: 1-week post therapy
2
Arm Function as Assessed by the Fugl-Meyer Score of Upper Extremity Function
Timeframe: 1 week post therapy
Trial details
NCT IDNCT05812794
SponsorThe University of Texas Health Science Center, Houston